Changing epidemiology of extended-spectrum β-lactamases in Argentina: emergence of CTX-M-15
- PMID: 22908156
- PMCID: PMC3486548
- DOI: 10.1128/AAC.00745-12
Changing epidemiology of extended-spectrum β-lactamases in Argentina: emergence of CTX-M-15
Abstract
A multicenter survey, carried out in 2010 in Argentina, showed an increased prevalence of extended-spectrum β-lactamase (ESBL)-producing enterobacteria, with some changes in the molecular epidemiology of circulating ESBLs. While enzymes of the CTX-M-2 group remain endemic, the emergence of CTX-M-15 and of enzymes of the CTX-M-8 and CTX-M-9 groups was observed. The CTX-M-15-positive isolates represented 40% of CTX-M producers and included representatives of Escherichia coli ST131 and Klebsiella pneumoniae ST11.
References
-
- Bado I, et al. 2010. Detection of class 1 and 2 integrons, extended-spectrum β-lactamases and qnr alleles in enterobacterial isolates from the digestive tract of intensive care unit inpatients. Int. J. Antimicrob. Agents 36:453–458 - PubMed
-
- Bartoloni A, et al. 9 February 2012. Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America. Clin. Microbiol. Infect. [Epub ahead of print.] doi:10.1111/j.1469-0691.2012.03807.x - DOI - PubMed
-
- Brigante G, et al. 2005. Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int. J. Antimicrob. Agents 25:157–162 - PubMed
-
- Bush K. 2010. Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558–564 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical